CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

AVBPArriVent BioPharma, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $30.28 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$1.49B
CountryUSA
RECENT INSIDER TRADES
  • 2026-02-03 · HILLHOUSE INVESTMENT MANAGEMENT, LTD. (10% Owner) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders165
Shares held48,753,632
Value$1.65B
Percent of shares outstanding98.88%
As of quarter end2026-06-30
RECENT NEWS
  • AVBP SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving ArriVent BioPharma
  • ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
  • ArriVent BioPharma: Phase 3 Failure Resets The Investment Case (Rating Downgrade)
  • AVBP: ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC
  • AVBP halted · News pending
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ArriVent BioPharma, Inc. (AVBP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit